Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthetic route for LND1088 linker avoids low-yield intermediates, ensuring scalable production and cost efficiency for ADC developers.
Patent CN115368435B details efficient SET0568 linker synthesis. Offers scalable production, high purity, and supply chain reliability for global ADC developers.
Advanced preparation of Glasdegib key intermediate via optimized Diels-Alder and ring-opening. Enhances purity and supply chain stability for API manufacturing.
Novel nickel-catalyzed direct cross-coupling of aryl fluorosulfates and bromides. Reduces steps, avoids toxic reagents. Reliable pharma intermediate supplier.
Novel low-cost route for Itopride HCl using N,N-dimethylethanolamine. Reduces cost by 30% and avoids high-pressure hydrogenation for scalable API manufacturing.
Patent CN120136770B reveals a green one-pot photocatalytic synthesis for anti-liver cancer indole intermediates, offering metal-free cost reduction and scalable supply chain solutions.
Patent CN102603592B reveals a novel DBTA resolution method for chiral aminopyrrolidines, offering high yield and optical purity for pharmaceutical supply chains.
Patent CN110642790B details a novel Rosuvastatin Calcium route using Evans auxiliaries. Achieve high purity solid intermediates and cost reduction in API manufacturing.
Patent CN1915976B reveals a high-yield route for 5-chloro-4-hydroxyl-2(1H)-pyridone. Discover cost-effective manufacturing and supply chain advantages for this key anticancer intermediate.
Patent CN108912020B details a safe, high-yield Suzuki coupling route for Orobactit intermediates, replacing hazardous lithiation for cost-effective API manufacturing.
Novel patent CN105085276A enables high-yield Eltrombopag intermediate production with significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106957307A reveals a novel dantrolene sodium derivative synthesis offering improved blood-brain barrier permeability and substantial supply chain cost advantages.
Novel Cs2CO3 catalyzed method for diarylmethyl phosphonates. High yield, mild conditions, cost-effective manufacturing for pharma intermediates.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Patent CN101056853B reveals a novel Pd-catalyzed regioselective hydrogenation route for isoindole derivatives, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN110028407A reveals a rare earth catalyzed method for spiro[cyclopropane-1,2'-indene]-1',3'-dione synthesis offering high stereoselectivity and supply chain advantages.
Novel LiI-promoted cyclization constructs aza[n.2.1] skeletons efficiently. Offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel sulfonyl-pyrrolidine route for Brivaracetam. Reduces chiral separation costs and simplifies purification for scalable API manufacturing.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Advanced synthesis of arylamine nitrogen mustard derivatives via patent CN106631857A. Offers reduced toxicity and enhanced therapeutic index for pharmaceutical manufacturing.